Susquehanna International Group’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.51M | Sell |
57,456
-6,312
| -10% | -$275K | ﹤0.01% | 2025 |
|
|
2025
Q1 | $1.75M | Buy |
63,768
+33,358
| +110% | +$913K | ﹤0.01% | 2475 |
|
|
2024
Q4 | $1.22M | Buy |
30,410
+6,696
| +28% | +$269K | ﹤0.01% | 2695 |
|
|
2024
Q3 | $1.12M | Buy |
23,714
+5,922
| +33% | +$280K | ﹤0.01% | 2526 |
|
|
2024
Q2 | $531K | Sell |
17,792
-7,839
| -31% | -$234K | ﹤0.01% | 3439 |
|
|
2024
Q1 | $1.03M | Sell |
25,631
-4,646
| -15% | -$187K | ﹤0.01% | 2606 |
|
|
2023
Q4 | $771K | Sell |
30,277
-59,637
| -66% | -$1.52M | ﹤0.01% | 3224 |
|
|
2023
Q3 | $1.25M | Sell |
89,914
-5,342
| -6% | -$74.3K | ﹤0.01% | 2308 |
|
|
2023
Q2 | $2.19M | Buy |
95,256
+22,579
| +31% | +$519K | ﹤0.01% | 1789 |
|
|
2023
Q1 | $2.15M | Buy |
72,677
+55,867
| +332% | +$1.66M | ﹤0.01% | 1874 |
|
|
2022
Q4 | $420K | Sell |
16,810
-48,394
| -74% | -$1.21M | ﹤0.01% | 3454 |
|
|
2022
Q3 | $1.42M | Buy |
+65,204
| New | +$1.42M | ﹤0.01% | 2069 |
|
|
2022
Q2 | – | Sell |
-33,240
| Closed | -$1.41M | – | 6290 |
|
|
2022
Q1 | $1.41M | Sell |
33,240
-5,959
| -15% | -$252K | ﹤0.01% | 2420 |
|
|
2021
Q4 | $2.49M | Buy |
39,199
+14,895
| +61% | +$945K | ﹤0.01% | 1740 |
|
|
2021
Q3 | $1.43M | Buy |
24,304
+6,651
| +38% | +$391K | ﹤0.01% | 2329 |
|
|
2021
Q2 | $856K | Sell |
17,653
-20,776
| -54% | -$1.01M | ﹤0.01% | 3186 |
|
|
2021
Q1 | $1.49M | Buy |
+38,429
| New | +$1.49M | ﹤0.01% | 2450 |
|